UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Medical expert witnesses need training and skill in healthcare systems

BMJ (Online), 2022-08, p.o2078

McGovern, Paul D

2022

Volltextzugriff (PDF)

Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia

Antimicrobial Agents and Chemotherapy, 2013-04, Vol.57 (4), p.1756-1762

2013

Volltextzugriff (PDF)

Healthcare staff need training in human factors

BMJ (Online), 2018-11, Vol.363, p.k4874

McGovern, Paul D

2018

Volltextzugriff (PDF)

Embracing artificial intelligence is the only way to avoid obsolescence

BMJ (Online), 2018-12, p.k5208

McGovern, Paul D

2018

Volltextzugriff (PDF)

Omadacycline for Community-Acquired Bacterial Pneumonia

The New England journal of medicine, 2019-02, Vol.380 (6), p.517-527

2019

Volltextzugriff (PDF)

Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial

The Lancet infectious diseases, 2019-10, Vol.19 (10), p.1080-1090

2019

Volltextzugriff (PDF)

Working when exhausted is unacceptable

BMJ (Online), 2017-09, Vol.358, p.j4191

McGovern, Paul D

2017

Volltextzugriff (PDF)

Cefepime–Taniborbactam in Complicated Urinary Tract Infection

The New England journal of medicine, 2024-02, Vol.390 (7), p.611-622

2024

Volltextzugriff (PDF)

Safety and efficacy of omadacycline by BMI categories and diabetes history in two Phase III randomized studies of patients with acute bacterial skin and skin structure infections

Journal of antimicrobial chemotherapy, 2021-04, Vol.76 (5), p.1315-1322

2021

Volltextzugriff (PDF)

An Integrated Safety Summary of Omadacycline, a Novel Aminomethylcycline Antibiotic

Clinical infectious diseases, 2019-08, Vol.69 (Supplement_1), p.S40-S47

2019

Volltextzugriff (PDF)

Omadacycline for Acute Bacterial Skin and Skin Structure Infections

Clinical infectious diseases, 2019-08, Vol.69 (Supplement_1), p.S23-S32

2019

Volltextzugriff (PDF)

Patient outcomes by baseline pathogen resistance phenotype and genotype in CERTAIN-1, a Phase 3 study of cefepime-taniborbactam versus meropenem in adults with complicated urinary tract infection

Antimicrobial agents and chemotherapy, 2024-07, Vol.68 (7)

2024

Volltextzugriff (PDF)

Early Clinical Response in Community-acquired Bacterial Pneumonia: From Clinical Endpoint to Clinical Practice

Clinical infectious diseases, 2019-08, Vol.69 (Supplement_1), p.S33-S39

2019

Volltextzugriff (PDF)

All-cause mortality imbalance in the tigecycline phase 3 and 4 clinical trials

International journal of antimicrobial agents, 2013-05, Vol.41 (5), p.463-467

2013

Volltextzugriff (PDF)

Omadacycline vs moxifloxacin in adults with community-acquired bacterial pneumonia

International journal of infectious diseases, 2021-03, Vol.104, p.501-509

2021

Volltextzugriff (PDF)

Distribution of 13-Valent Pneumococcal Conjugate Vaccine Streptococcus pneumoniae Serotypes in US Adults Aged ≥50 Years With Community-Acquired Pneumonia

The Journal of infectious diseases, 2013-12, Vol.208 (11), p.1813-1820

2013

Volltextzugriff (PDF)

The Effect of Verapamil, a P-gp Inhibitor, on the Pharmacokinetics, Safety, and Tolerability of Omadacycline in Healthy Adults: A Phase I, Open-Label, Single-Sequence Study

European journal of drug metabolism and pharmacokinetics, 2021-01, Vol.46 (1), p.85-92

2021

Volltextzugriff (PDF)

Efficacy and Safety of Omadacycline Versus Linezolid in Acute Bacterial Skin and Skin Structure Infections in Persons Who Inject Drugs

Infectious diseases and therapy, 2022-02, Vol.11 (1), p.517-531

2022

Volltextzugriff (PDF)

Safety and efficacy of omadacycline for treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in patients with mild-to-moderate renal impairment

International journal of antimicrobial agents, 2021-02, Vol.57 (2), p.106263-106263, Article 106263

2021

Volltextzugriff (PDF)

Patient Warming Excess Heat: The Effects on Orthopedic Operating Room Ventilation Performance

Anesthesia and analgesia, 2013-08, Vol.117 (2), p.406-411

2013

Volltextzugriff (PDF)

Clinical response and mortality in tigecycline complicated intra-abdominal infection and complicated skin and soft-tissue infection trials

International journal of antimicrobial agents, 2015-09, Vol.46 (3), p.346-350

2015

Volltextzugriff (PDF)

Pancreatitis in tigecycline Phase 3 and 4 clinical studies

Journal of antimicrobial chemotherapy, 2014-03, Vol.69 (3), p.773-778

2014

Volltextzugriff (PDF)

Plasma lipid profile and incident ischemic stroke: The Atherosclerosis Risk in Communities (ARIC) Study

Stroke (1970), 2003-03, Vol.34 (3), p.623-631

2003

Volltextzugriff (PDF)

Efficacy of Omadacycline Versus Moxifloxacin in the Treatment of Community-Acquired Bacterial Pneumonia by Disease Severity: Results From the OPTIC Study

Open forum infectious diseases, 2021-06, Vol.8 (6), p.ofab135-ofab135

2021

Volltextzugriff (PDF)

Stroke incidence and survival among middle-aged adults : 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) Cohort

Stroke (1970), 1999-04, Vol.30 (4), p.736-743

1999

Volltextzugriff (PDF)

1 – 25 von 704

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(632)
Mit Volltextzugriff
(581)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(432)
Life Sciences & Biomedicine
(390)
Humans
(350)
Female
(237)
Male
(216)
Adult
(146)
Middle Aged
(139)
Biological And Medical Sciences
(122)
Medical Sciences
(114)
Aged
(106)
Public, Environmental & Occupational Health
(60)
General & Internal Medicine
(59)
Risk Factors
(59)
Medicine, General & Internal
(55)
Adolescent
(46)
Infectious Diseases
(43)
Social Sciences
(42)
Cardiovascular System & Cardiology
(36)
Substance Abuse
(35)
Treatment Outcome
(34)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Medical expert witnesses need training and skill in healthcare systems

Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia

Healthcare staff need training in human factors

Embracing artificial intelligence is the only way to avoid obsolescence

Omadacycline for Community-Acquired Bacterial Pneumonia

Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial

Working when exhausted is unacceptable

Cefepime–Taniborbactam in Complicated Urinary Tract Infection

Safety and efficacy of omadacycline by BMI categories and diabetes history in two Phase III randomized studies of patients with acute bacterial skin and skin structure infections

An Integrated Safety Summary of Omadacycline, a Novel Aminomethylcycline Antibiotic

Omadacycline for Acute Bacterial Skin and Skin Structure Infections

Patient outcomes by baseline pathogen resistance phenotype and genotype in CERTAIN-1, a Phase 3 study of cefepime-taniborbactam versus meropenem in adults with complicated urinary tract infection

Early Clinical Response in Community-acquired Bacterial Pneumonia: From Clinical Endpoint to Clinical Practice

All-cause mortality imbalance in the tigecycline phase 3 and 4 clinical trials

Omadacycline vs moxifloxacin in adults with community-acquired bacterial pneumonia

Distribution of 13-Valent Pneumococcal Conjugate Vaccine Streptococcus pneumoniae Serotypes in US Adults Aged ≥50 Years With Community-Acquired Pneumonia

The Effect of Verapamil, a P-gp Inhibitor, on the Pharmacokinetics, Safety, and Tolerability of Omadacycline in Healthy Adults: A Phase I, Open-Label, Single-Sequence Study

Efficacy and Safety of Omadacycline Versus Linezolid in Acute Bacterial Skin and Skin Structure Infections in Persons Who Inject Drugs

Safety and efficacy of omadacycline for treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in patients with mild-to-moderate renal impairment

Patient Warming Excess Heat: The Effects on Orthopedic Operating Room Ventilation Performance

Clinical response and mortality in tigecycline complicated intra-abdominal infection and complicated skin and soft-tissue infection trials

Pancreatitis in tigecycline Phase 3 and 4 clinical studies

Plasma lipid profile and incident ischemic stroke: The Atherosclerosis Risk in Communities (ARIC) Study

Efficacy of Omadacycline Versus Moxifloxacin in the Treatment of Community-Acquired Bacterial Pneumonia by Disease Severity: Results From the OPTIC Study

Stroke incidence and survival among middle-aged adults : 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) Cohort

Suchergebnisse filtern